Rucript F 160mg/10mg Tablet
Marketer
Cardimind Pharmaceuticals
Salt Composition
Fenofibrate (160mg) + Rosuvastatin (10mg)
Overview Rucript F 160mg/10mg Tablet
LipiComb 160mg/10mg tablets combine two lipid-reducing agents to decrease elevated cholesterol and triglyceride levels in the bloodstream. This dual-action therapy is indicated when lifestyle modifications (like a low-fat diet) prove insufficient. It contributes to a reduced risk of cardiovascular events. LipiComb can be administered with or without food, at any time of day, but consistency is recommended for optimal adherence. Dosage is tailored by your physician based on your lipid profile and response. While high cholesterol and triglycerides often present without symptoms, discontinuation can exacerbate the condition, increasing stroke and heart disease risks. Regular lipid profile monitoring is crucial. This medication is one component of a comprehensive treatment plan that necessitates a heart-healthy diet, regular physical activity, smoking cessation, responsible alcohol consumption, and weight management, if needed. Maintain a generally balanced diet while minimizing high-fat foods. Common, usually transient, side effects include nausea, abdominal discomfort, constipation, headache, gas, and myalgia. Persistent symptoms, jaundice, unusual bleeding or bruising, or recurring severe muscle pain warrant immediate medical attention. Periodic liver function testing may be advised. This medication is contraindicated in liver disease (e.g., abnormal liver function tests, persistent jaundice). Inform your physician of kidney issues, pregnancy, pregnancy plans, or breastfeeding before use. Diabetics should monitor their blood glucose levels closely, as hyperglycemia may occur.
Primary Ingredients of Rucript F 160mg/10mg Tablet
No text provided to rephrase.
Uses of Rucript F 160mg/10mg Tablet
Cardiovascular event prevention and hypercholesterolemia management
Major Benefits of Rucript F 160mg/10mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rucript F 160mg/10mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Rucript F 160mg/10mg Tablet:
- Headache
- Muscle pain
- Constipation
- Abnormal liver function tests
- Joint pain
- Elevated creatine kinase
- Diabetes
How to use Rucript F 160mg/10mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 160mg/10mg Rucript F tablet whole; avoid crushing, chewing, or breaking it. While consumption with or without food is acceptable, consistent timing is recommended for optimal results.
How Rucript F 160mg/10mg Tablet works:
Lipitor-Fen 160mg/10mg tablets combine fenofibrate and rosuvastatin to reduce blood lipid levels. Fenofibrate decreases triglyceride concentrations, whereas rosuvastatin inhibits the production of low-density lipoprotein (LDL) cholesterol. Concurrently, both medications elevate high-density lipoprotein (HDL) cholesterol levels.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use and Rucript F 160mg/10mg tablets is contraindicated.
PregnancyUNSAFE
Administering Rucript F 160mg/10mg tablets to pregnant individuals presents a substantial risk. Pregnant women should consult their physician before use, as research in both animal and human subjects indicates potentially serious adverse consequences for fetal development.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Rucript F 160mg/10mg tablets are likely incompatible. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Rucript F 160mg/10mg Tablets.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Rucript F 160mg/10mg tablets, as dose modification may be necessary. Consult your physician for guidance. Rucript F 160mg/10mg tablets are contraindicated in patients with severely compromised kidney function.
LiverCAUTION
Patients with liver impairment should use Rucript F 160mg/10mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Rucript F 160mg/10mg tablets are contraindicated in patients with severe or active liver disease.
What if you forget to take Rucript F 160mg/10mg Tablet :
Should you forget a Rucript F 160mg/10mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rucript F 160mg/10mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | HEART |
3,018 People bought this recently